Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Therapy areas
Immuno-oncology
Immuno-oncology
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-oncology
Selectively Targeting Cancerous T-Cells Using CAR-T Therapy
Biospace News
-
July 16, 2019
Immuno-oncology
Provectus Provides Update on GI Tumor Program for Investigational Cancer Drug PV-10
Immuno-oncology
MDNA55 Shows Promising Results in Models of Ovarian Cancer
Immuno-oncology
Bristol-Myers Squibb’s Opdivo Fails to Show Superiority to Bayer’s Nexavar in Liver Cancer
Immuno-oncology
ADC Therapeutics Presents Clinical Data on ADCT-402 and ADCT-301 in Subtypes of Relapsed or Refractory Lymphoma at the 15th International Conference on Malignant Lymphoma
Immuno-oncology
Orion Biotechnology Reports Additional Positive Preclinical Data for OB-002 in the...
Biospace News
-
June 20, 2019
0
Immuno-oncology
Menarini Ricerche at the ASCO Annual Meeting 2019 With Three Different...
Biospace News
-
May 23, 2019
0
Immuno-oncology
Polyphor Announces Presentation of New Survival Data on Balixafortide at the...
Biospace News
-
May 20, 2019
0
Immuno-oncology
Sirnaomics Publishes Data for Lead Candidate STP705 in Cancer Model as...
Firstwordpharma News
-
May 16, 2019
0
Immuno-oncology
AstraZeneca Continues to Redefine Cancer Treatment at The 2019 ASCO Annual...
Biospace News
-
May 16, 2019
0
1
2
3
...
25
Page 1 of 25
- Advertisement -
MOST POPULAR
Ascletis and 3-V Biosciences Announce NASH Strategic License and Series E...
February 13, 2019
Zymeworks and LEO Pharma Enter into Bispecific Antibody Licensing and Research...
October 24, 2018
Regeneron Discloses Two Deaths from its Bispecific Antibody RGN1979
May 8, 2019
Vericel Enters into Exclusive License Agreement with MediWound for North American...
May 7, 2019
Load more
HOT NEWS
Others
June 2019 decisions news release
Orphan-paediatric
Drug for children with spinal muscular atrophy too expensive, HSE says ...
Commercial
Top Cities in the U.S. for Biopharma/STEM Jobs
Deals
Vaccibody announces collaboration to study VB10.16 and atezolizumab (Tecentriq) in advanced...
